News Daily News HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act L.A. McKeown January 13, 2023
News Conference News TCT 2022 Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID Michael O'Riordan September 17, 2022
News Daily News AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions Shelley Wood August 15, 2022
News Daily News Quadruple Therapy Costs Prohibitive for Many HFrEF Patients L.A. McKeown June 21, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Features Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle Shelley Wood October 08, 2021
News Conference News SCAI 2019 National Cardiogenic Shock Initiative Shows Potential to Increase Survival Yael L. Maxwell May 23, 2019
News Conference News ACC 2019 New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin Shelley Wood March 26, 2019
News Daily News Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock? Caitlin E. Cox July 30, 2018
News Conference News The Structural Heart Disease Summit 2018 Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions Shelley Wood June 22, 2018
News Opinion Fellow Talk Hemodynamics Galore: What I Learned at the C3 Summit Tiffany Patterson, MBBS July 27, 2016